80506 Federal Register / Vol. 75, No. 245 / Wednesday, December 22, 2010 / Notices 

ESTIMATED ANNUALIZED BURDEN HOURS—Continued 

Respondents Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hrs) 

Stakeholders ................................................................................................................................

Industry leader recommend stores .............................................................................................. 3 30 30/60 

Community leader recommend stores ........................................................................................ 3 30 30/60 

Shari Steinberg, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2010–32077 Filed 12–21–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30 Day–11–10GX] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

The Centers for Disease Control and 

Prevention (CDC) publishes a list of 

information collection requests under 

review by the Office of Management and 

Budget (OMB) in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

Chapter 35). To request a copy of these 

requests, call the CDC Reports Clearance 

Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written 

comments to CDC Desk Officer, Office of 

Management and Budget, Washington, 

DC 20503 or by fax to (202) 395–5806. 

Written comments should be received 

within 30 days of this notice. 

Proposed Project 

Persistence of Viable Influenza Virus 

in Aerosols—New—National Institute 

for Occupational Safety and Health 

(NIOSH), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

The National Institute for 

Occupational Safety and Health 

(NIOSH) is authorized to conduct 

research to advance the health and 

safety of workers under Section 20(a) (1) 

of the 1970 Occupational Safety and 

Health Act. Influenza continues to be a 

major public health concern because of 

the substantial health burden from 

seasonal influenza and the potential for 

a severe pandemic. Although influenza 

is known to be transmitted by infectious 

secretions, these secretions can be 

transferred from person to person in 

many different ways, and the relative 

importance of the different pathways is 

not known. The likelihood of the 

transmission of influenza virus by small 

infectious airborne particles produced 

during coughing and breathing is 

particularly unclear. The question of 

airborne transmission is especially 

important in healthcare facilities, where 

influenza patients tend to congregate 

during influenza season, because it 

directly impacts the infection control 

and personal protective measures that 

should be taken by healthcare workers. 

The purpose of this study is to measure 

the amount of viable influenza virus in 

airborne particles that are produced by 

patients when they cough, and the size 

and quantity of the particles carrying 

the virus. A better understanding of the 

amount of potentially infectious 

material released by patients and the 

size of the particles carrying the virus 

will assist in determining the possible 

role of airborne transmission in the 

spread of influenza and in devising 

measures to prevent it. 

Volunteer participants will be 

recruited by a test coordinator using a 

flyer describing the study. Interested 

potential participants will be screened 

using a short health questionnaire to 

verify that they have influenza-like 

symptoms and that they do not have any 

medical conditions that would preclude 

their participation. Based on a previous 

study using similar forms, we estimate 

that the health questionnaire will 

require about 5 minutes to complete. 

Qualified participants who agree to 

participate in the study will be asked to 

read and sign an informed consent form. 

Based on the previous study, we 

estimate that the informed consent form 

will take about 10 minutes to read and 

sign. Once the informed consent form is 

signed, the participant will have their 

oral temperature measured, two 

nasopharyngeal swabs will be collected, 

and the participant will be asked to 

cough into an aerosol particle collection 

system. These steps will take about 25 

minutes. The airborne particles 

produced by the participant during 

coughing will be collected and tested. 

There are no costs to the respondents 

other than their time. The total 

estimated annual burden hours are 84. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

Initial participants (phase 1) .............. Health questionnaire ........................ 44 1 5/60 4 

Qualified participants (phase 1) ........ Informed Consent form .................... 40 1 10/60 7 

No form; Time required for testing. .. 40 1 25/60 17 

Initial participants (phase 2) .............. Health questionnaire ........................ 44 1 5/60 4 

Qualified participants (phase 2) ........ Informed Consent form .................... 40 1 10/60 7 

No form; Time required for testing. .. 40 1 25/60 17 

Initial participants (phase 3) .............. Health questionnaire ........................ 44 1 5/60 4 

Qualified participants (phase 3) ........ Informed Consent form .................... 40 1 10/60 7 

No form; Time required for testing. .. 40 1 25/60 17 


srobinson on DSKHWCL6B1PROD with NOTICES
Federal Register / Vol. 75, No. 245 / Wednesday, December 22, 2010 / Notices 80507 

Dated: December 16, 2010. 

Catina Conner, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2010–32076 Filed 12–21–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60 Day–11–11BF] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instrument, call 404–639–5960 and send 

comments to Carol E. Walker, Acting 

CDC Reports Clearance Officer, 1600 

Clifton Road NE., MS–D74, Atlanta, 

Georgia 30333; or send an e-mail to 

omb@cdc.gov. 

Comments are invited on (a) whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have a 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

Contact Investigation Outcome 

Reporting Forms—New—National 

Center for Emerging, Zoonotic and 

Infectious Diseases (NCEZID), Centers 

for Disease Control and Prevention 

(CDC). 

Background and Brief Description 

CDC proposes to collect passengerlevel, epidemiologic, demographic, and 

health status data from State/local 

Health Departments and maritime 

operators at the conclusion of contact 

investigations of individuals believed to 

have been exposed to a communicable 

disease during travel. The information 

requested by CDC would be obtained by 

the health departments or maritime 

operators while conducting the contact 

investigation according to their 

established policies and procedures, 

and would be reported to CDC on a 

voluntary basis. This information will 

assist CDC in fulfilling its regulatory 

responsibility to prevent the 

importation of communicable diseases 

from foreign countries (42 CFR part 71) 

and interstate control of communicable 

diseases in humans (42 CFR part 70). To 

perform these tasks in a streamlined 

manner and ensure that all relevant 

information is collected in the most 

efficient and timely manner possible, 

Quarantine Stations use a number of 

forms: Contact Investigation Outcome 

Reporting Forms: (1) Optional TB Air/ 

Land Contact Investigation Outcome 

Reporting, (2) Optional Measles, 

Mumps, or Rubella Air/Land Contact 

Investigation Outcome Reporting, (3) 

Optional General Air/Land Contact 

Investigation Outcome Reporting Form, 

(4) Optional TB Maritime Contact 

Investigation Outcome Reporting Form, 

(5) Optional Measles, Mumps or Rubella 

Maritime Contact Investigation Outcome 

Reporting Form, (6) Optional General 

Maritime Contact Investigation Outcome 

Reporting Form. 

Section 361 of the Public Health 

Service (PHS) Act (42 USC 264) 

authorizes the Secretary of Health and 

Human Services to make and enforce 

regulations necessary to prevent the 

introduction, transmission or spread of 

communicable diseases from foreign 

countries into the United States. The 

regulations that implement this law, 42 

CFR parts 70 and 71, require 

conveyances to report an ‘‘ill person’’ or 

any death onboard to authorized 

quarantine officers and other personnel 

to inspect and undertake necessary 

control measures with respect to 

conveyances (e.g., airplanes, cruise 

ships), persons, and shipments of 

animals and etiologic agents in order to 

protect the public health. The 

notification is made possible by 

contacting individuals who may have 

been exposed to a communicable 

disease during travel and their contacts, 

and investigating this exposure so that 

the necessary medical or public health 

interventions can be implemented. 

CDC provides state and local health 

departments and maritime conveyance 

operators with information to notify and 

contact individuals and further 

investigate this exposure by contacting 

others who may have been potentially 

exposed to disease. However, there 

currently is no standardized tool or form 

to collect pertinent information 

regarding the outcome of such 

investigations. 

To address the need to inform CDC of 

additional actions that may be needed to 

further protect public health based on 

the outcome of the contact 

investigations, CDC has developed six 

forms to assist health departments and 

maritime conveyance operators in 

reporting back to CDC. The forms are 

specific to the nature of the 

investigation; Tuberculosis (TB), 

Measles, Mumps, and Rubella or the 

General forms specific to other diseases 

of public health concern. The purpose 

of the forms is the same: To collect 

information to help CDC quarantine 

officials to fully understand the extent 

of disease spread and transmission 

during travel and to inform the 

development and or refinement of 

investigative protocols, aimed at 

reducing the spread of communicable 

disease. 

All six forms collect the following 

categories of information: Heath status 

of traveler, clinical history including 

diagnosis, and interventions related to 

exposure. 

Respondents are state and local health 

departments and maritime conveyance 

operators. Respondents will use these 

standardized forms to submit data to 

CDC for each individual contacted via a 

secure means of their choice, e.g., Webbased application, fax or e-mail. 

The estimated total burden on the 

public, included in the chart below, can 

vary a great deal depending on the 

number of flights and the number of 

individuals identified as contacts that 

are assigned to a given health 

jurisdiction in the U.S. There is no cost 

to respondents other than their time. 


srobinson on DSKHWCL6B1PROD with NOTICES